Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Chronic metabolic acidosis in pediatric patients may also reduce growth rates, which may decrease the maximal height achieved
Obstructive sleep apnea (OSA) Zepbound injection is also approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity
Arch Physiol Biochem
(2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
There have been reports of patients who used the drug being diagnosed with severe gastroparesis, or stomach paralysis
Brief post-injection facial flushing The most consistent community feedback is a warmth and visible flush in the face, neck, and upper chest within 5-15 minutes of injection, fading by 30 minutes
